Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era

Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era

Glandular metastases (GMs) (pancreas, breast, parotid, thyroid, or contralateral adrenal) are rare in metastatic clear cell renal cell carcinoma (mccRCC). In a multicenter study we have assessed outcome from mccRCC with or without GMs.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologic Oncology 2016-04, Vol.34 (4), p.167
Hauptverfasser: Gravis, Gwenaelle, Chanez, Brice, Derosa, Lisa, Beuselinck, Benoit, Barthelemy, Philippe, Laguerre, Brigitte, Brachet, Pierre-Emmanuel, Joly, Florence, Escudier, Bernard, Harrison, David J, Laird, Alexander, Vasudev, Naveen, Ralph, Christy, Larkin, James, Lote, Hazel, Salem, Naji, Walz, Jochen, Thomassin, Jeanne, Sfumato, Patrick, Stewart, Grant D, Boher, Jean Marie
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Glandular metastases (GMs) (pancreas, breast, parotid, thyroid, or contralateral adrenal) are rare in metastatic clear cell renal cell carcinoma (mccRCC). In a multicenter study we have assessed outcome from mccRCC with or without GMs.
ISSN:1078-1439